Study on IgG Promoter As Probe to Evaluate Safetyof Injections in Pre-Clinic

Yugang Wang,Lele Li,Fan Lei,Aihua Liang,Dongming Xing,Lijun Du
DOI: https://doi.org/10.4268/cjcmm20100116
2010-01-01
Abstract:OBJECTIVE To construct an effective system screening and evaluating possible injections and components inducing allergy type II. METHOD Transfect IgG promoter-regulated green fluorescent protein expressing plasmid into RPMI-8226 cell. The number of fluorescent cells after drug treatment was calculated and statistically evaluated. RESULT Tween 80 can suppress the expression of IgG effectively, and puerarin has activity of stimulating IgG expression, and the system has no response to KCl-treatment. No effect of Yuxingcao (Herba Houttuyniae) injection on this system is observed. CONCLUSION IgG promoter-drove green fluorescent protein expressing cell line can be used as system screening injections and components inducing allergy type II based on stimulating IgG promoter activity. Tween 80 can suppress the expression of IgG at the transcriptional level. Four batches of Yuxingcao injection cannot induce allergy type II by activating IgG expression.
What problem does this paper attempt to address?